![Jean-Jacques Bertrand](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Jacques Bertrand
Directeur/Membre du Conseil chez
NEOVACS
Profil
Jean-Jacques Bertrand is currently the Chairman at the Canadian Network for Vaccines & Immunotherapeutics, Chairman at Viroxis SA, Vice Chairman at Brive Rugby SA, Chairman at JJB SAS, Director at Pierre Fabre Participations SAS, Director at Neovacs SA, Venture Partner at Truffle Capital SAS, and Manager at SCI du 26 Place du Peuple.
He previously held positions as Chairman & Chief Executive Officer at Aventis Pasteur Sa, Chief Executive Officer at Rhone Poulenc Rorer, Chief Executive Officer at Aventis Pharma SARL, Chairman & Chief Executive Officer at Sanofi Pasteur, CEO-Pharmaceutical Operations at Rhône-Poulenc Santé, Chairman at Guerbet SA, Chairman-Supervisory Board at Pierre Fabre SA, Chairman-Supervisory Board at Cytheris SA, Chairman at Leem, Chairman at Fédération Françaises des Industries de Santé, Non-Executive Director at Muzicall Ltd., Director at B3G SA, Director at La Fondation pour la Recherche Médicale, and Independent Director at Abivax SA. He obtained his undergraduate degree from École des Hautes Études Commerciales de Paris.
Postes actifs de Jean-Jacques Bertrand
| Sociétés | Poste | Début |
|---|---|---|
| NEOVACS | Directeur/Membre du Conseil | - |
Pierre Fabre Participations SAS
 Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology and cosmetic products | Directeur/Membre du Conseil | 25/08/2018 |
Viroxis SA | Président | - |
Brive Rugby SA | Directeur/Membre du Conseil | - |
Canadian Network for Vaccines & Immunotherapeutics | Président | 28/06/2010 |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital invests in companies located in France with revenues of EUR 5 million. The firm focuses on life sciences (medtech & biotech) and deeptech applied to finance (fintech & Insurtech) sectors. It provides financing for early stage capital requirements with an investment size of EUR 5 - 15 million. It acts as a lead investor and it takes a seat on the board of directors. The firm makes follow-on investments. | Analyste en capital-investissement | 17/12/2009 |
Anciens postes connus de Jean-Jacques Bertrand
| Sociétés | Poste | Fin |
|---|---|---|
JJB SAS | Président | 08/07/2024 |
| ABIVAX | Directeur/Membre du Conseil | 11/07/2023 |
B3G SA
 B3G SA Specialty TelecommunicationsCommunications Provides broadband telephone operating services | Directeur/Membre du Conseil | 30/10/2013 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jean-Jacques Bertrand
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Muzicall Ltd.
 Muzicall Ltd. Wireless TelecommunicationsCommunications Provides ringback tone services | Communications |
Guerbet SA
 Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Aventis Pasteur Sa
 Aventis Pasteur Sa Pharmaceuticals: MajorHealth Technology Researches and develops human and animal pharmaceutical products | Health Technology |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology and cosmetic products | Health Technology |
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Manufactures and distributs pharmaceutical products. | Process Industries |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Neovacs SA
 Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Truffle Capital SAS
Truffle Capital SAS Investment ManagersFinance Truffle Capital invests in companies located in France with revenues of EUR 5 million. The firm focuses on life sciences (medtech & biotech) and deeptech applied to finance (fintech & Insurtech) sectors. It provides financing for early stage capital requirements with an investment size of EUR 5 - 15 million. It acts as a lead investor and it takes a seat on the board of directors. The firm makes follow-on investments. | Finance |
B3G SA
B3G SA Specialty TelecommunicationsCommunications Provides broadband telephone operating services | Communications |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Health Technology |
Leem | |
La Fondation pour la Recherche Médicale | |
Canadian Network for Vaccines & Immunotherapeutics | |
Fédération Françaises des Industries de Santé
 Fédération Françaises des Industries de Santé Fédération Françaises des Industries de Santé is a private company based in Boulogne-Billancourt, France. | |
Rhône-Poulenc Santé | |
Viroxis SA | |
Brive Rugby SA | |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
JJB SAS |
Choisissez Zonebourse 
